These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2355588)

  • 41. Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus.
    Biesecker G; Lavin L; Ziskind M; Koffler D
    N Engl J Med; 1982 Feb; 306(5):264-70. PubMed ID: 7054697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunoglobulins and complement in systemic lupus erythematosus, rheumatoid arthritis and juvenile rheumatoid arthritis].
    Dostal Ts; Shusta A; Gana I; Bardfeld R
    Ter Arkh; 1974; 46(11):98-100. PubMed ID: 4216106
    [No Abstract]   [Full Text] [Related]  

  • 43. Alterations of complement components in disease.
    Luskin AT; Tobin MC
    Am J Med Technol; 1982 Sep; 48(9):749-56. PubMed ID: 6215862
    [No Abstract]   [Full Text] [Related]  

  • 44. [Study of B-lymphocytes with receptors to C3 component of complement in patients with glomerulonephritis and systemic lupus erythematosus].
    Gordovskaia NB; Bulanova TD; Traianova TG
    Ter Arkh; 1977; 49(7):45-50. PubMed ID: 331546
    [No Abstract]   [Full Text] [Related]  

  • 45. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Significance of the study of complement in glomerulonephritis. Research on some serum complement fractions and their detection in renal biopsies with the use of microscopy and immunofluorescence].
    Martini PF; Camussi G; Segoloni G; Rotunno M; Triolo G; Mangiarotti G; Messina M; Caramello E
    Recenti Prog Med; 1978 Mar; 64(3):354-73. PubMed ID: 351753
    [No Abstract]   [Full Text] [Related]  

  • 47. [Complement activity in the serum and synovial fluid of various rheumatoid diseases].
    Richter H; Thumb N; Gangl A; Zilcher H; Hornich R
    Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:106-10. PubMed ID: 4538173
    [No Abstract]   [Full Text] [Related]  

  • 48. [Complement activation of alternative pathway in renal diseases and systemic lupus erythematosus (author's transl)].
    Nakayama S
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):447-61. PubMed ID: 529617
    [No Abstract]   [Full Text] [Related]  

  • 49. [Activated complement in systemic lupus erythematosus].
    Porcel JM; Ordi J
    Med Clin (Barc); 1991 Feb; 96(4):135-7. PubMed ID: 2023487
    [No Abstract]   [Full Text] [Related]  

  • 50. [Complement and its components in selected autoimmune diseases].
    Pietruska Z
    Pol Tyg Lek; 1980 Jan; 35(1):27-30. PubMed ID: 6154287
    [No Abstract]   [Full Text] [Related]  

  • 51. Immune complexes and complement in rheumatoid arthritis.
    Lambert PH; Casali P; Nydegger U
    Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):301-15. PubMed ID: 534786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
    Hunder GG; McDuffie FC; Clark RJ
    J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.
    Hedberg H; Lundh B; Laurell AB
    Clin Exp Immunol; 1970 May; 6(5):707-12. PubMed ID: 5477926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Quantitative determination of the 3d component of the complement in human sera].
    Bragiel I; Skowrońska H
    Acta Haematol Pol; 1974; 5(2):145-52. PubMed ID: 4134126
    [No Abstract]   [Full Text] [Related]  

  • 56. [The 3d component of complement (B1A globulin) in collagenoses and its diagnostic significance].
    Popov PN; Speranskiĭ AI; Nasonova VA
    Ter Arkh; 1974; 46(3):50-7. PubMed ID: 4133373
    [No Abstract]   [Full Text] [Related]  

  • 57. [Serum total complement activity].
    Kitamura H
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():53-6. PubMed ID: 20942000
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical significance of the estimations of complement and immune complexes].
    Yoshida H; Watanabe K
    Rinsho Byori; 1989 Dec; 37(12):1317-23. PubMed ID: 2693771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serum complement levels in systemic lupus erythematosus].
    Morita M; Nishishita S; Amano T; Ofuji T
    Arerugi; 1971 Mar; 20(3):159-68. PubMed ID: 4101817
    [No Abstract]   [Full Text] [Related]  

  • 60. [Detection of circulating immune complexes in patients with lupus erythematosus, viral hepatitis and rheumatoid arthritis using radioactive marked C1q].
    Nydegger U; Lambert PH; Miescher PA
    Verh Dtsch Ges Inn Med; 1974; 80():1575-7. PubMed ID: 4217986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.